Bank of America’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Bank of America's IPXL Position: Q2 2018 in Review
Bank of America sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 227,221 shares — an estimated $4.42M sold.
Bank of America first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $4.42M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Bank of America reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Bank of America sold 227,221 Impax Laboratories, Inc. shares in Q2 2018, an estimated $4.42M.
- Bank of America first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Bank of America's Impax Laboratories, Inc. position peaked at $4.42M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.